Top Markets
Coin of the day
Hcmed Hcmed

Hcmed

6934
Rank in Stocks #20836
HCmed Innovations Co Ltd. specializes in creating advanced solutions for... HCmed Innovations Co Ltd. specializes in creating advanced solutions for respiratory treatment through the application of mesh technology. Their product line features devices such as Pulmogine and AdheResp. Beyond its core offerings, the company delivers extensive analytical services focused on aerosol characterization, helping clients optimize and develop new inhaled therapeutic products. This analytical assistance is provided in strict adherence to Pharmacopoeia standards. Founded on October 6, 2014, by Jason Cheng, Leon Tsai, Shaogi Huang, and Simon Hsieh, HCmed maintains its principal office in Taipei, Taiwan.
Share Price
$3.83
Last synced: 2026-02-24
Market Cap
$120.91M
Change (1 day)
2.55%
Change (1 year)
80.49%
Country
TW
Trade Hcmed (6934)

Category

P/S ratio for Hcmed (6934)
P/S ratio as of 2026 TTM: 0
According to Hcmed latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Hcmed from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
10.17 -
US
10.13 -
NL
11.28 -
US
2.95 -
AU
- -
CH